Marcy l'Etoile, France - March 8, 2010. Solid operating and financial performance:
- Strong growth in sales: up 10.4% - At constant exchange rates
- Significant increase in operating margin: up 14.1%, at 17.4% of sales
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on Friday, March 5, 2010 to approve the consolidated financial statements for the year ended December 31, 2009. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors. The financial statements have been audited and the Statutory Auditors are in the process of issuing an unqualified opinion.
Download
- Filename
- biomerieux_pr_results_2009_en.pdf
- Size
- 63 KB
- Format
- application/pdf